155 related articles for article (PubMed ID: 34843627)
1. The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada.
Uthayakumar S; Tadrous M; Vigod SN; Kitchen SA; Gomes T
Depress Anxiety; 2022 Feb; 39(2):156-162. PubMed ID: 34843627
[TBL] [Abstract][Full Text] [Related]
2. Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022.
Chai G; Xu J; Goyal S; Woods C; Ho A; Song J; Dal Pan G
JAMA Psychiatry; 2024 Apr; 81(4):396-405. PubMed ID: 38198145
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada.
Campitelli MA; Bronskill SE; Maclagan LC; Harris DA; Cotton CA; Tadrous M; Gruneir A; Hogan DB; Maxwell CJ
JAMA Netw Open; 2021 Aug; 4(8):e2118441. PubMed ID: 34338794
[TBL] [Abstract][Full Text] [Related]
4. Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020.
Jones CM; Guy GP; Board A
Drug Alcohol Depend; 2021 Feb; 219():108486. PubMed ID: 33421802
[TBL] [Abstract][Full Text] [Related]
5. Prescription Drug Dispensing to US Children During the COVID-19 Pandemic.
Chua KP; Volerman A; Conti RM
Pediatrics; 2021 Aug; 148(2):. PubMed ID: 34285080
[TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study.
Antoniou T; Pajer K; Gardner W; Penner M; Lunsky Y; Tadrous M; Mamdani M; Gozdyra P; Juurlink DN; Gomes T
Front Pediatr; 2023; 11():1282845. PubMed ID: 38146536
[TBL] [Abstract][Full Text] [Related]
7. Trends in Delirium and New Antipsychotic and Benzodiazepine Use Among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic.
Reppas-Rindlisbacher C; Boblitz A; Fowler RA; Lapointe-Shaw L; Sheehan KA; Stukel TA; Rochon PA
JAMA Netw Open; 2023 Aug; 6(8):e2327750. PubMed ID: 37548976
[TBL] [Abstract][Full Text] [Related]
8. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada.
Tu K; Mamdani MM; Hux JE; Tu JB
J Am Geriatr Soc; 2001 Oct; 49(10):1341-5. PubMed ID: 11890493
[TBL] [Abstract][Full Text] [Related]
9. Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study.
Antoniou T; McCormack D; Kitchen S; Pajer K; Gardner W; Lunsky Y; Penner M; Tadrous M; Mamdani M; Juurlink DN; Gomes T
BMC Public Health; 2023 Jan; 23(1):85. PubMed ID: 36631810
[TBL] [Abstract][Full Text] [Related]
10. Changes in antidepressant use in Australia: A nationwide analysis (2015-2021).
de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson SA
Aust N Z J Psychiatry; 2023 Jan; 57(1):49-57. PubMed ID: 35176912
[TBL] [Abstract][Full Text] [Related]
11. Dispensing patterns of mental health medications before and during the COVID-19 pandemic in Alberta, Canada: An interrupted time series analysis.
Ying LT; Yarema MC; Bousman CA
Int J Psychiatry Med; 2023 Mar; 58(2):172-184. PubMed ID: 35502998
[TBL] [Abstract][Full Text] [Related]
12. Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment.
Antoniou T; McCormack D; Kitchen S; Pajer K; Gardner W; Lunsky Y; Penner M; Tadrous M; Mamdani M; Juurlink DN; Gomes T
BMC Pediatr; 2023 Oct; 23(1):519. PubMed ID: 37858122
[TBL] [Abstract][Full Text] [Related]
13. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19.
Rabeea SA; Merchant HA; Khan MU; Kow CS; Hasan SS
Daru; 2021 Jun; 29(1):217-221. PubMed ID: 33715138
[TBL] [Abstract][Full Text] [Related]
14. Changes in Psychiatric Medication Use During the COVID-19 Pandemic in a Pediatric Long-Term Care Facility.
Harris C; Sumy MSA; Feygin YB; Huxol H; Tejuoso A; Kluthe T; Bickel S
J Child Adolesc Psychopharmacol; 2024 May; 34(4):210-213. PubMed ID: 38682450
[No Abstract] [Full Text] [Related]
15. Effects of COVID-19 pandemic on anxiety and depression in primary care: A cohort study in Ontario, Canada.
Stephenson E; Tu K; Ji C; Butt D; Crampton N; Gronsbell J; O'Neill B
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35947415
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study.
Zeitouny S; McGrail K; Tadrous M; Wong ST; Cheng L; Law M
BMJ Open; 2024 Jan; 14(1):e070031. PubMed ID: 38176877
[TBL] [Abstract][Full Text] [Related]
17. Trends in Psychotropic Dispensing Among Older Adults with Dementia Living in Long-Term Care Facilities: 2004-2013.
Vasudev A; Shariff SZ; Liu K; Burhan AM; Herrmann N; Leonard S; Mamdani M
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1259-1269. PubMed ID: 26525997
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic dispensing during the COVID-19 pandemic: analysis of Welsh primary care dispensing data.
Wasag DR; Cannings-John R; Hughes K; Ahmed H
Fam Pract; 2022 May; 39(3):420-425. PubMed ID: 34755180
[TBL] [Abstract][Full Text] [Related]
19. Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic.
Sanchez MA; Fuchs B; Tubert-Bitter P; Mariet AS; Jollant F; Mayet A; Quantin C
BMC Med; 2022 Sep; 20(1):306. PubMed ID: 36100914
[TBL] [Abstract][Full Text] [Related]
20. Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis.
De Bandt D; Haile SR; Devillers L; Bourrion B; Menges D
BMJ Ment Health; 2024 Feb; 27(1):. PubMed ID: 38413052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
